392 JOURNAL OF COSMETIC SCIENCE (28) M. Rebuffe-Scrive, J. Eldh, L. Hafstrom, et al., Metabolism of mammary, abdominal and femoral adipocytes in women before and after menopause, Metabolism, 35, 792-797 (1986). (29) S. B. Pedersen, K. Kristensen, P. A. Hermann, et al., Estrogen controls lipolysis by upregulating alpha-2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha: Implications for female fat distribution, J. Clin. Endocrinol. Metab., 89, 1869-1878 (2004). (30) X. Xu, G. DePergola, and P. Bjorntorp, Testosterone increases lipolysis and the number of 13-adren­ ergic receptors in male rat adipocytes, Endocrinology, 128, 379-383 (1991). (31) M. Quinkler, W. Oelkers, and S. Diederich, Clinical Implications of glucocorticoid metabolism by l l-l3-hydroxysteroid dehydrogenases in target tissues, Eur. J. Endocrinol., 144, 87-97 (2001). (32) S. Engeli, J. Bohnke, M. Feldpausch, et al., Regulation of ll-l3-hydroxysteroid dehydrogeanse genes in human adipose tissue: Influence of central obesity and weight loss, Obes. Res., 12, 9-17 (2004). (33) H. Masuzaki, and J. Flier, Tissue-specific glucocorticoid reactivating enzyme ll-!3-hydroxysteroid dehydrogenase type-1 (lll3HSD-l)-A promising drug target for the treatment of metabolic syn­ drome, Curr. Drug, Targ. Imm. Endocrin. Metab. Disord., 3, 255-262 (2003). (34) N. Morton, L. Ramage, and J. Seckl, Down-regulation of adipose ll-!3-hydroxysteroid dehydrogenase type-1 by high fat feeding in mice: A potent adaptive mechanism counteracting metabolic disease, Endocrinol., 145, 2707-2712 (2004). (35) W. Banks, The many lives of leptin, Peptides, 25, 331-338 (2004). (36) G. Alvarez, T. Ballard, S. Beske, et al., Subcutaneous obesity is not associated with sympathetic neural activation, Am. J. Physiol. Heart Circ. Physiol., 287, 414--418 (2004). (37) P. Putignano, A. Brunani, A. Dubini, et al., Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: A dose response study,]. Endocrinol. Invest., 26, 111-116 (2003). (38) P. Pananetti, G. Garrapa, F. Mantero, et al., Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions, Clin. Exp. Hypertens, 26, 387- 398 (2004). (39) T. Nagy, B. Gower, C. Trowbridge, et al., Effects of gender ethnicity body composition and fat distribution on serum leptin concentrations in children, J. Clin. Endocrin. Metab., 82, 2148-2152 (1997). (40) J. Potter, L. Rennie-Tankersley, and E. Mezey, Leptin deficiency prevents the activation of the murine alpha 2(1) collagen promoter by acetaldehyde, Arch. Biochem. Biophys., 426, 73-77 (2004). (41) M. Tang, J. Potter, and E. Mezey, Activation of the human alphal (I) collagen promoter by leptin is not mediated by transforming growth factor beta responsive elements, Biochem. Biophys. Res. Commun., 312, 629-633 (2003). (42) M. Matsubara, S. Maruoka, and S. Katayose, Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women, Eur J. Endocrinol., 147, 173-180 (2002). (43) B. Spiegelman, PPAR--y: Adipogenic regulator and thiazolidinedione receptor, Diabetes, 47, 507-514 (1998). (44) P. Trayhurn, The biology of obesity, Proc. Nutr. Soc., 64, 31-38 (2005). (45) G. Fantuzzi, Adipose tissue, adipokines, and inflammation,]. Allergy Clin. Immunol., 115, 911-919 (2005). (46) L. Martin,]. Woo, S. Daniels, E. Goodman, and L. Dolan, The relationship of adiponectin with insulin and lipids are strengthened with increasing adiposity,J. Clin. Endocrinol. Metab., 90, (2005). (47) T. Kadowaki and T. Yamanuchi, Adiponectin and adiponectin receptors, Endocr. Rev., 26, 439-451 (2005 ). (48) J. Fernandez-Real, M. Pugeat, A. Lopez-Bermejo, H. Barnet, and W. Ricart, Corticosteroid-binding globulin affects the relationship between circulating adiponectin and cortisol in men and women, Metabolism, 54, 584-589 (2005). (49) M. Gniadecka, 0. Nielson, S. Wessel, et al., Water and protein structure in photoaged and chronically aged skin,]. Invest. Dermatol. 111, 1129-1133 (1998). (50) J. Nuutinen, R. Ikaheimo, and T. Lahtinen, Validation of a new dielectric device to assess changes of tissue water in skin and subcutaneous fat, Physiol. Meas., 25, 447-454 (2004). (51) S. Kim, J. Park, and W. Moon, Dystropic breast calcifications in patients with collagen disease, Clin. Imaging, 28, 6-9 (2004). (52) Y. Kudva, C. Reynolds, T. O'Brien, et al., Mastopathy and diabetes. Curr. Diabetes Rep., 3, 56-59 (2003). (53) N. Cho, K. Oh, K. Park, and T. Noh, Sclerosing lobular hyperplasia: Sonographic pathological correlation, Eur Radial., 13, 1645-1650 (2003).

ANALYSIS AND REVIEW OF CEllULITE 393 (54) B. Neudecker, R. Stern, and M. Connolly, Aberrant serum hyaluronan and hyaluronidase levels in scleroderma, Br. J. Dermatol., l, 469--476 (2004). (55) M. Santiago, D. de Castro, C. Costa, et al., Keloidal scleroderma, Clin. Rheumatol., 23, 50-51 (2004). (56) S. Shuster, The causes of striae distensae, Acta Derm. Venereal., Suppl. 59, 161-169 (1979). (57) M. Katayama, K. Normura, M. Ujihara, T. Obara, and H. Demura, Age-dependent decline in cortisol levels and clinical manifestations in patients with ACTH-independent Cushing's syndrome, Clin. Endocrinol., 49, 311-316 (1998). (58) A. Szuba and S. Rockson, Lymphedema: Anatomy, physiology and pathogenesis, Vascular Med., 2, 321-326 (1997). (59) T. Ryan, and D. de Berker, The interstitium, the connective tissue environment of the lymphatic and angiogenesis in human skin, Clin. Dermatol., 13, 451--458 (1995). (60) L. Smalls, C. Y. Lee, J. Whitestone, W. J. Kitzmiller, R.R. Wickett, and M. 0. Visscher, Quanti­ tative model of cellulite: Three-dimensional skin surface topography, biophysical characterization, and relationship to human perception,] Cosmet. Sci., 56, 105-120 (2004). (61) T. Callaghan, Evaluating cellulite: Reality redirecting the dream to dispel the myth, Proceedings of the 23rd IFSCC Congress, Orlando, Florida, October 2004. (62) T. Callaghan, C. Alessi-Fox, et al., (in preparation, 2005).